For example, the SGLT2 inhibitor, which has cardiac and renal protective effects (Dapagliflozin, Canagliflozin, Empagliflozin), is a commonly used drug for the treatment of diabetes mellitus. This evidence concerns the gene SLC5A2 and diabetes mellitus.